Home / Publication / Prediction of Olanzapine Exposure in Individual Patients Using Physiologically-based Pharmacokinetic Modeling and Simulation

論文

Prediction of Olanzapine Exposure in Individual Patients Using Physiologically-based Pharmacokinetic Modeling and Simulation

Author(s): Thomas M. Polasek, Geoffrey T. Tucker, Michael J. Sorich, Michael D. Wiese, Titus Mohan, Amin Rostami-Hodjegan, Porntipa Korprasertthaworn, Vidya Perera, Andrew Rowland

Year: 2017年11月30日

Merck Advances Pediatric Oncology with Innovative ADC Modeling

事例紹介

Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings

お知らせ

Modeling amyloid plaque turnover dynamics improves characterization of drug effects

論文

Using M&S to Evaluate Oncology Drug Dosing

ブログ

Powered by Translations.com GlobalLink Web Software

Prediction of Olanzapine Exposure in Individual Patients Using Physiologically-based Pharmacokinetic Modeling and Simulation

Prediction of Olanzapine Exposure in Individual Patients Using Physiologically-based Pharmacokinetic Modeling and Simulation

Merck Advances Pediatric Oncology with Innovative ADC Modeling

Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings

Modeling amyloid plaque turnover dynamics improves characterization of drug effects

Using M&S to Evaluate Oncology Drug Dosing

メルマガ登録

クイックアクセス

ソリューション

お問合せ